Low-Dose Iron as Effective as High-Dose, with Fewer Side Effects

December 20, 2013

1 Min Read
Low-Dose Iron as Effective as High-Dose, with Fewer Side Effects

CLEARFIELD, UtahA low-dose ferrous bisglycinate proved equivalent to higher dose ferrous salt for expectant women's hematological and iron statuses, says new research published in Journal of Perinatal Medicine. The results are insightful for the prevention of iron deficiency, which is prevalent in pregnant women, using lower dosages (J Perinat Med. 2013 Oct 24:1-10. doi: 10.1515/).

In this peer-reviewed study, ferrous bisglycinate was taken by 80 Danish pregnant women throughout their pregnancy with measurements taken at 15 to 19, 27 to 29 and 36 to 37 weeks," said Max Motyka, director of sales and marketing for Albion's Human Nutrition Division. The study tested Aminojern®, a product containing Ferrochel from Albion Human Nutrition.

Women either took 25 mg of ferrous bisglycinate elemental iron or 50 mg of ferrous sulfate elemental iron daily. Researchers found no significant differences in the two groups' hematological status and iron status. However, women receiving bisglycinate supplementation had lower gastrointestinal complaints and healthier baby birth weights.

Explore the various types of iron and their advantages in the INSIDER Iron Buyers Guidebook.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like